Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel Nr1h3-/- mouse model exhibits AMD-like pathology

May 13, 2022

Autoantibody-induced murine dry eye disease model mimics human disease

May 13, 2022

Allorion Therapeutics presents TYK2 inhibitor ARTS-011 for the treatment of inflammatory disease

May 13, 2022

Novel Fanconi anemia xenograft murine model to test immunotherapy

May 13, 2022

Inimmune develops TLR7/8 agonist for monotherapy or combination with anti-PD-1 therapy

May 12, 2022

Aro's Centyrin-targeted siRNA conjugates show potential for Pompe disease

May 12, 2022

CRB-601 shows promising antitumor activity alone or in combination with immunotherapy

May 12, 2022

Myrtelle launches new research program for Pelizaeus-Merzbacher disease

May 12, 2022

GT-02329 shows promise in in vitro and in vivo Gaucher disease models

May 12, 2022

Targeting bromodomain in Brg-1 unveiled as a promising approach for uveal melanoma

May 12, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026